Fevertree Drinks (FEVR) Partnership summary

Opening remarks and agenda

• Announced a transformational long-term strategic partnership in the U.S. with Molson Coors, aiming for significant revenue and profit growth.

• Outlined the agenda to discuss strategic rationale, transaction details, and financial outlook.

• Partnership effective 1 February 2025, with exclusive US sales, distribution, and production rights.

Objectives of the partnership

• Unlock the next phase of growth in the U.S., leveraging Molson Coors' scale, platform, and marketing investment.

• Expand into new channels, categories, and occasions, including adult soft drinks and RTDs.

• Transform Fever-Tree’s US business into a more efficient, scalable operation.

Partner introductions and roles

• Molson Coors will acquire 100% of Fever-Tree's US trading subsidiary and an 8.5% equity stake in Fever-Tree Drinks plc.

• Molson Coors will handle sales, distribution, marketing execution, and production in the U.S.

• Fever-Tree retains full control of brand identity, vision, and new product development for the U.S. market.

• A joint governance committee with equal senior management from both parties will oversee strategic planning and investment decisions.